<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">Lung tuberculosis</z:e>, resulting from decreased cellular immunity, is associated with <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and is most frequently seen in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, <z:hpo ids='HP_0001909'>leukemia</z:hpo> and T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>MATERIAL AND METHODS: In the period 1995-2000, 20 patients (pts) with <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">lung tuberculosis</z:e> and <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancies</z:e> were analyzed, out of whom 7 (35%) were females, with mean age of 56 years, and 13 (65%) were males, with mean age of 55 years </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS AND DISCUSSION: Among the affected, 8 (40%) patients had Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, 5 (25%) suffered from <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, 4 (2%) had <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, 1 (5%) manifested a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, 1 (5%) <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> and 1 (5%) had <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The average time from completing a specific <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapy and development of <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculous</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was 20 months, except in 3 cases who had a <z:e sem="disease" ids="C0848852,C0376545" disease_type="Neoplastic Process" abbrv="">hematological malignancy</z:e> and <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">lung tuberculosis</z:e> at the time of initial diagnosis </plain></SENT>
<SENT sid="4" pm="."><plain>The diagnosis was made on the basis of positive findings of sputum smear in 15 (75%) pts, by bronchological examination and sputum analysis in 3 (15%) pts, lymph node biopsy and sputum analysis in 1 (5%) case, pleural biopsy in 1 (5%) patient, and finally confirmed by culture in 19 (95%) pts </plain></SENT>
<SENT sid="5" pm="."><plain>Radiological examination revealed fibrocaseous <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> in 14 (70%) pts, out of whom 12 with bilateral and 2 with unilateral changes, 3 (15%) manifested <z:e sem="disease" ids="C0041321" disease_type="Disease or Syndrome" abbrv="">miliary tuberculosis</z:e>, and 3 (15%) had <z:hpo ids='HP_0002202'>pleural effusion</z:hpo> and <z:e sem="disease" ids="C0041296" disease_type="Disease or Syndrome" abbrv="tb|tbc">tuberculosis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Successful outcome was achieved in 18 (90%) pts, while lethal outcome was reported in 2 (10%) cases with miliary <z:e sem="disease" ids="C0041327" disease_type="Disease or Syndrome" abbrv="">pulmonary tuberculosis</z:e> </plain></SENT>
</text></document>